Document Detail


Overview of recent clinical trials in heart failure: what is the current standard of care?
MedLine Citation:
PMID:  11208254     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heart failure develops as a consequence of cardiac injury. As the heart begins to fail to meet the body's metabolic demands, the renin angiotensin aldosterone system (RAAS) and the sympathetic nervous system are activated. These interrelated systems act in concert to facilitate cardiac output and tissue perfusion. Though these neurohormonal systems are initially compensatory, evidence suggests that they promote deleterious cardiac remodeling and myocyte destruction. Recent studies in patients with heart failure have targeted the RAAS and sympathetic nervous system for therapeutic intervention. This article reviews major recent multicenter, randomized, double-blind, and placebo-controlled trials in heart failure that have resulted in a new standard of care for patients with this devastating disease.
Authors:
D R Murray; J Dugan
Related Documents :
20363214 - Urocortins in heart failure.
12656654 - Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable ...
25465924 - Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acut...
17920924 - The surgical treatment of end-stage heart failure.
17878634 - Comparison of the incidence of acute coronary event after balloon angioplasty vs. stent...
16459054 - Acute effects of hemodialysis on left ventricular function evaluated by tissue doppler ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology in review     Volume:  8     ISSN:  1061-5377     ISO Abbreviation:  Cardiol Rev     Publication Date:    2000 Nov-Dec
Date Detail:
Created Date:  2001-11-06     Completed Date:  2001-12-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9304686     Medline TA:  Cardiol Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  340-7     Citation Subset:  IM    
Affiliation:
Department of Medicine/Cardiology (MC 7872), University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Aldosterone Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiology / standards
Clinical Trials as Topic*
Drug Therapy, Combination
Female
Follow-Up Studies
Guidelines as Topic*
Heart Failure / diagnosis,  drug therapy*,  mortality
Humans
Male
Receptors, Angiotensin / antagonists & inhibitors*
Renin-Angiotensin System / physiology
Severity of Illness Index
Survival Analysis
Sympathetic Nervous System / physiology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Aldosterone Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Receptors, Angiotensin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aortic valve surgery in the elderly.
Next Document:  Noninvasive diagnostic testing of coronary artery disease in women.